Journal article
Iatrogenic Creutzfeldt-Jakob disease at the millennium
P Brown, M Preece, JP Brandel, T Sato, L McShane, I Zerr, A Fletcher, RG Will, M Pocchiari, NR Cashman, JH D'Aignaux, L Cervenáková, J Fradkin, LB Schonberger, SJ Collins
Neurology | LIPPINCOTT WILLIAMS & WILKINS | Published : 2000
Abstract
The causes and geographic distribution of 267 cases of iatrogenic Creutzfeldt-Jakob disease (CJD) are here updated at the millennium. Small numbers of still-occurring cases result from disease onsets after longer and longer incubation periods following infection by cadaveric human growth hormone or dura mater grafts manufactured and distributed before the mid-1980s. The proportion of recipients acquiring CJD from growth hormone varies from 0.3 to 4.4% in different countries, and acquisition from dura mater varies between 0.02 and 0.05% in Japan (where most cases occurred). Incubation periods can extend up to 30 years, and cerebellar onsets predominate in both hormone and graft recipients (in..
View full abstract